Andersen with Azzurra Capital and The Club Dealers in the acquisition of Domixtar Pharmaceuticals
With a team led by partners Marcello Rabbia and Alberto Trainotti, Andersen Italia supported Azzurra Capital and The Club Dealers in the acquisition of 100% of the pharmaceutical group Domixtar Pharmaceuticals DMX from the controlling companies of the private equity funds Alto Partners SGR and Trilantic Europe.
Our professionals’ support focused on the tax due diligence, deal structuring, and negotiation of the tax clauses in the contracts. Mario Bono coordinated the deal structure; Davide Centurelli, Michele Furnari, and Manuela Piccaluga carried out the due diligence of the target, assisted by Vanessa Saracino, Giacomo Obetti, and Noemi Tozza.
Azzurra Capital and The Club Dealers have entered into binding agreements to acquire 100% of the share capital of Domixtar Pharmaceutical DMX, an Italian leader in the CDMO (Contract Development and Manufacturing Organization) sector. The shares are being sold by the private equity funds Alto Partners SGR and Trilantic Europe.
Azzurra Capital is a private equity investment firm headquartered in Luxembourg with offices in Dubai, London, and Milan, focused on acquiring stakes in family-owned or entrepreneurial companies, typically leaders in their sectors, with the aim of fostering their sustainable growth.
The Club Dealers is a private equity investment vehicle founded by its founding partners, Carlo Mammola and Enrico Ricotta, prominent figures in the investment sector with over 35 years of experience in the venture capital and private equity markets.
DMX operates in the pharmaceutical sector as a contract developer and manufacturer of finished dosage forms. Established in 2024 from the merger of two leading Italian operators, Mipharm and Doppel Farmaceutici, it has been financially managed by Alto Partners SGR and Trilantic Europe.
“The transaction – states Marcello Rabbia, partner at Andersen Italia – places in the hands of Azzurra Capital and The Club Dealers a company with a strong corporate reputation and over 25 years of market presence, built on reliable manufacturing, long-term relationships with clients and suppliers, and a high level of operational service. This is a well-considered investment aimed at generating strong returns and continuous value creation.”
- TopLegal
- Finance Community
- Legal Community
- Milano Finanza
- Il Nordest Quotidiano
- Be Beez
- Investors in Healthcare
- Global Legal Chronicle
Links
- Il Sole 24Ore (PDF, 288.39 KB)